Zazen Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 20-12-2024
- Paid Up Capital ₹ 0.50 M
as on 20-12-2024
- Company Age 27 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.31 Cr
as on 20-12-2024
- Satisfied Charges ₹ 3.83 Cr
as on 20-12-2024
- Revenue 82.71%
(FY 2022)
- Profit 88.45%
(FY 2022)
- Ebitda 18.54%
(FY 2022)
- Net Worth 328.01%
(FY 2022)
- Total Assets 28.07%
(FY 2022)
About Zazen Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹6.31 Cr. The company has closed loans amounting to ₹3.83 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mehul Mehta and Rupal Mehta serve as directors at the Company.
- CIN/LLPIN
U24230MH1997PTC108726
- Company No.
108726
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jun 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Zazen Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mehul Mehta  | Director | 12-Jun-1997 | Current |
| Rupal Mehta | Director | 16-Apr-2021 | Current |
Financial Performance of Zazen Pharma.
Zazen Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 82.71% increase. The company also saw a substantial improvement in profitability, with a 88.45% increase in profit. The company's net worth Soared by an impressive increase of 328.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zazen Pharma?
In 2022, Zazen Pharma had a public holding of 38.49%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 Nov 2024 | ₹0.35 M | Open |
Others Creation Date: 10 Apr 2024 | ₹4.78 M | Open |
Others Creation Date: 26 Mar 2024 | ₹0.18 M | Open |
How Many Employees Work at Zazen Pharma?
Unlock and access historical data on people associated with Zazen Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zazen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zazen Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
